Analysis for SNPS
- 📈 Growth — 23/30
- 💰 Profitability — 14/20
- 🏦 Financial Health — 15/20
- 💵 Valuation — 13/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
Over the eight quarters from 2024 Q3 to 2026 Q2, revenues rose from about $1.53B to about $2.28B, a net gain of roughly $0.75B (+49%). Net income fluctuated, peaking near $1.10B in 2024 Q4 before winding down to the mid-to-low tens of millions by 2026 Q1–Q2, signaling uneven quarterly profitability despite a clear top-line expansion.
💰 Margins & Cash Flow
Gross profit remained sizable, with margins often in the mid-60s to low-70s percent range and improving when mix favored higher-margin offerings. Operating leverage was visible in select quarters (notably 2024 Q4) but cooled in later periods. Net cash flow from operating activities was positive across most quarters, while investing and financing cash flows produced swings; overall, cash generation remained solid in several periods, but cash burn appeared in some financing cycles.
🛡️ Balance Sheet & Liquidity
Balance sheet quality is strong, with robust equity and noncurrent assets. Long-term debt hovered in the double-digit billions while cash balances ranged around a few billions, yielding a meaningful but manageable net leverage. Liquidity supports ongoing operations and financing activity.
⚠️ Key Drivers & Risks
- Drivers: AI/EDA adoption and sustained semiconductor design activity; rising demand for Synopsys tooling.
- Risks: Cyclicality of tech and semiconductor cycles; high leverage and sensitivity to valuation multiples.